Cary L. Majors - 04 Jun 2024 Form 4 Insider Report for STERIS plc (STE)

Role
SVP and President, Healthcare
Signature
/s/ Ronald E. Snyder, Authorized Representative under Power of Attorney
Issuer symbol
STE
Transactions as of
04 Jun 2024
Net transactions value
$0
Form type
4
Filing time
06 Jun 2024, 16:38:23 UTC
Previous filing
05 Jun 2024
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STE Ordinary Shares Award $0 +2,379 +22% $0.000000 13,054 04 Jun 2024 Direct F1
holding STE Ordinary Shares 67 04 Jun 2024 See Footnote Below F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STE Employee Stock Option (right to buy) Award $0 +12,200 $0.000000 12,200 04 Jun 2024 Ordinary Shares 12,200 $251.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of June 4, 2024, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027.
F2 Units representing 67 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 31, 2024.
F3 This option becomes exercisable as follows: 3,050 on June 4, 2025; 3,050 on June 4, 2026; 3,050 on June 4, 2027 and 3,050 on June 5, 2028.